it is my thought process that if PD has to raise significant cash at any price similar to this - it's game over.
with his experience and credentials, if he can't take $16m and grow us significantly enough that we 1) never need to raise again (my preference) or 2) raise at a significantly higher price to this - then I won't be a shareholder.
However, I believe $16m should take us into 2022 comfortably, and the potential growth of the company even throughout 2021 is significant.
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-17159
-
- There are more pages in this discussion • 3,254 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
-0.001(3.33%) |
Mkt cap ! $47.43M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.8¢ | $13.26K | 457.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3370 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 1256022 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3491 | 0.029 |
6 | 1694822 | 0.028 |
8 | 1053639 | 0.027 |
4 | 385422 | 0.026 |
4 | 3079000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 1256022 | 3 |
0.032 | 24900 | 1 |
0.033 | 410208 | 3 |
0.034 | 5874 | 1 |
0.035 | 40000 | 1 |
Last trade - 15.03pm 15/07/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online